Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000020230 | SCV000220581 | pathogenic | Niemann-Pick disease, type C1 | 2014-08-07 | criteria provided, single submitter | literature only | |
Eurofins Ntd Llc |
RCV000723413 | SCV000700313 | uncertain significance | not provided | 2016-10-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000020230 | SCV000941919 | pathogenic | Niemann-Pick disease, type C1 | 2024-01-27 | criteria provided, single submitter | clinical testing | This sequence change replaces glycine, which is neutral and non-polar, with tryptophan, which is neutral and slightly polar, at codon 992 of the NPC1 protein (p.Gly992Trp). This variant is present in population databases (rs80358254, gnomAD 0.003%). This missense change has been observed in individuals with Niemann-Pick disease type C (PMID: 9634529, 11545687, 16778374, 20718790, 26666848, 28222799). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 2960). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt NPC1 protein function with a positive predictive value of 95%. This variant disrupts the p.Gly992 amino acid residue in NPC1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 11333381, 16126423, 26984608). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000020230 | SCV001163436 | pathogenic | Niemann-Pick disease, type C1 | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000723413 | SCV001781732 | pathogenic | not provided | 2022-10-10 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 12955717, 11479732, 16778374, 12401890, 10521290, 11545687, 20718790, 9634529, 16126423, 24001525, 26666848, 29961769, 9245994, 31497485, 32222928, 20301473, 32138288, 34535129) |
Revvity Omics, |
RCV000020230 | SCV003815154 | likely pathogenic | Niemann-Pick disease, type C1 | 2022-03-15 | criteria provided, single submitter | clinical testing | |
OMIM | RCV000003094 | SCV000023252 | pathogenic | Niemann-Pick disease, type D | 1998-07-01 | no assertion criteria provided | literature only | |
Gene |
RCV000020230 | SCV000040574 | not provided | Niemann-Pick disease, type C1 | no assertion provided | literature only | ||
Sing |
RCV000020230 | SCV000853138 | likely pathogenic | Niemann-Pick disease, type C1 | 2017-06-07 | no assertion criteria provided | curation | |
Natera, |
RCV000020230 | SCV001453837 | pathogenic | Niemann-Pick disease, type C1 | 2020-09-16 | no assertion criteria provided | clinical testing | |
Hereditary Research Laboratory, |
RCV000020230 | SCV001653519 | likely pathogenic | Niemann-Pick disease, type C1 | 2021-06-02 | no assertion criteria provided | clinical testing |